Trial reportThe Journal of clinical endocrinology and metabolism2025
Effect of Hypoglycemia on QT Interval in Individuals With and Without Type 2 Diabetes: A Randomized Crossover Trial.
Trial report in The Journal of clinical endocrinology and metabolism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundOur goal was to determine in healthy individuals and individuals with type 2 diabetes the impact of repeated episodes of hypoglycemia on the corrected QT (QTc) interval and the time course for QTc recovery. Further, since hypoglycemia increases aldosterone and patients with primary aldosteronism have prolonged QTc, we also determined whether mineralocorticoid receptor blockade prevents hypoglycemia-induced QTc alterations.
methodsTwenty-seven healthy participants completed a double-blinded crossover trial contrasting 3 experimental conditions: (1) euglycemia, (2) hypoglycemia, and (3) hypoglycemia with mineralocorticoid receptor blockade pretreatment. Sixteen participants with type 2 diabetes completed 1 condition, hypoglycemia. Hyperinsulinemic clamps were performed to induce the hypoglycemic and euglycemic conditions. Electrocardiograms were performed before, during, and after the clamps.
resultsHealthy participants had a significant (P < .0001) prolongation of QTc during both the morning and afternoon hypoglycemic clamps as compared with euglycemic clamps (morning hypoglycemia vs euglycemia: 439.06 ± 41.18 ms vs 406.96 ± 26.16 ms; afternoon hypoglycemia vs euglycemia: 441.50 ± 34.36 ms vs 407.78 ± 19.18 ms). Mineralocorticoid receptor (MR) blockade did not alter the response to hypoglycemia. Participants with diabetes achieved a significant prolongation of QTc during the afternoon hypoglycemia only (afternoon hypoglycemia vs morning baseline: 461.96 ± 49.14 vs 428.90 ± 28.54, P < .05). In both participant populations, QTc intervals were similar to baseline 90 minutes after return to euglycemia and the following day.
conclusionHypoglycemia prolonged QTc in healthy participants, and this was not altered by MR blockade. In individuals with type 2 diabetes, 2 hypoglycemic episodes were required to achieve prolongation. Reassuringly, in both study populations, hypoglycemia-induced QTc prolongation resolved quickly with no apparent residual effects the next day.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.